The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection

Data analysis
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub Samples were excluded from analysis if Western blotting showed poor knockdown in siRNA or shRNA experiments.
Reproducibility of data was addressed by keeping culturing of cells the same as well as keeping the timing of experiments consistant.
No randomization was performed. Samples were allocated to different groups based upon over-expression or knockdown of specific proteins.
For computer based quantitation of Rhodamine 123 uptake, images of random fields were acquired, and all samples were analyzed using the same software parameters. Morphological analysis of mitochondria was performed by a qualitative grouping of organelle shapes into 4 broad categories. For mtDNA image quantitation, samples were manually thresholded then mtDNA localization was determined by non bias analysis software.
Human anti-MxA rabbit polyclonal and human anti-MxB rabbit polyclonal antibodies were developed by the McNiven lab, other anti-MxB (Guinea Pig and Rabbit) antibodies were a generous gift from Dr. Ilkka Julkunen and Dr. Chen Liang, respectively. The anti-MX2 rabbit polyclonal antibody (NBP1-81018) was from Novus (Centennial, CO). The anti-CoxIV (3E11) rabbit mAb and (4D11-B3-E8) mouse mAb; anti-Tom20 (D8T4N) rabbit mAb; anti-OPA1 (D6U6N) rabbit mAb; anti-GM130 (D6B1) XP rabbit mAb; anti-GAPDH (D16H11) XP rabbit mAb were from Cell Signaling (Danvers, MA). The anti-OPA1 mouse mAb was from BD Biosciences (San Jose, CA). The anti-mtDNA antibody was from EMD Millipore (Temecula, CA). The anti-calnexin antibody was from Abcam (Cambridge, MA). The anti-Actin antibody was from Sigma (St. Louis, MO). Goat anti-rabbit and goat anti-mouse secondary antibodies conjugated to either Alexa-Fluor-488 or -594 used for immunofluorescence staining were all obtained from Thermo Fisher Scientific (Rockford, IL), and HRP-conjugated goat anti-rabbit and goat anti-mouse antibodies for Western blot analysis were from BioSource International, Inc. (Camarillo, CA).
Commercial antibodies were used per manufacturers recommendations and additionally validated by Western blotting of overexpression or knockdown samples. Rabbit polyclonal antibodies made by McNiven lab were purified on a peptide column and validated by Western blot against pre-immune serum, and over-expression or knockdown samples.
